Compare IVA & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IVA | NBN |
|---|---|---|
| Founded | 2011 | 1872 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 804.2M | 836.7M |
| IPO Year | 2020 | N/A |
| Metric | IVA | NBN |
|---|---|---|
| Price | $4.60 | $106.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $17.14 | ★ $102.00 |
| AVG Volume (30 Days) | ★ 228.7K | 95.9K |
| Earning Date | 09-29-2025 | 02-05-2026 |
| Dividend Yield | N/A | ★ 0.04% |
| EPS Growth | N/A | ★ 38.19 |
| EPS | N/A | ★ 10.63 |
| Revenue | $19,929,536.00 | ★ $214,699,000.00 |
| Revenue This Year | N/A | $11.59 |
| Revenue Next Year | N/A | $11.26 |
| P/E Ratio | ★ N/A | $9.97 |
| Revenue Growth | N/A | ★ 36.17 |
| 52 Week Low | $2.11 | $78.17 |
| 52 Week High | $7.98 | $113.01 |
| Indicator | IVA | NBN |
|---|---|---|
| Relative Strength Index (RSI) | 55.13 | 68.13 |
| Support Level | $4.12 | $98.15 |
| Resistance Level | $4.58 | $108.15 |
| Average True Range (ATR) | 0.21 | 3.08 |
| MACD | 0.03 | 0.57 |
| Stochastic Oscillator | 77.97 | 71.16 |
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.